Lataa...

Intermittent Metronomic Drug Schedule Is Essential for Activating Antitumor Innate Immunity and Tumor Xenograft Regression

Metronomic chemotherapy using cyclophosphamide (CPA) is widely associated with antiangiogenesis; however, recent studies implicate other immune-based mechanisms, including antitumor innate immunity, which can induce major tumor regression in implanted brain tumor models. This study demonstrates the...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Chen, Chong-Sheng, Doloff, Joshua C, Waxman, David J
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Neoplasia Press Inc. 2014
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3924543/
https://ncbi.nlm.nih.gov/pubmed/24563621
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!